Ascendis Pharma A/S
NASDAQ:ASND

Watchlist Manager
Ascendis Pharma A/S Logo
Ascendis Pharma A/S
NASDAQ:ASND
Watchlist
Price: 126.03 USD -1.28% Market Closed
Market Cap: 7.2B USD
Have any thoughts about
Ascendis Pharma A/S?
Write Note

Net Margin
Ascendis Pharma A/S

-154.1%
Current
-2 780%
Average
-7.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-154.1%
=
Net Income
-489.5m
/
Revenue
317.6m

Net Margin Across Competitors

Country Company Market Cap Net
Margin
DK
Ascendis Pharma A/S
NASDAQ:ASND
7.3B USD
-154%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-21 040%
US
Abbvie Inc
NYSE:ABBV
301B USD
9%
US
Amgen Inc
NASDAQ:AMGN
162B USD
13%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
127.5B USD
-5%
US
Gilead Sciences Inc
NASDAQ:GILD
115.4B USD
0%
US
Epizyme Inc
F:EPE
94.1B EUR
-392%
AU
CSL Ltd
ASX:CSL
138B AUD
18%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
88.6B USD
34%
US
Seagen Inc
F:SGT
39.3B EUR
-33%
NL
argenx SE
XBRU:ARGX
34.1B EUR
-14%
Country DK
Market Cap 7.3B USD
Net Margin
-154%
Country FR
Market Cap 6T USD
Net Margin
-21 040%
Country US
Market Cap 301B USD
Net Margin
9%
Country US
Market Cap 162B USD
Net Margin
13%
Country US
Market Cap 127.5B USD
Net Margin
-5%
Country US
Market Cap 115.4B USD
Net Margin
0%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country AU
Market Cap 138B AUD
Net Margin
18%
Country US
Market Cap 88.6B USD
Net Margin
34%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country NL
Market Cap 34.1B EUR
Net Margin
-14%

Profitability Report

View the profitability report to see the full profitability analysis for Ascendis Pharma A/S.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-154.1%
=
Net Income
-489.5m
/
Revenue
317.6m
What is the Net Margin of Ascendis Pharma A/S?

Based on Ascendis Pharma A/S's most recent financial statements, the company has Net Margin of -154.1%.